choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Telmisartan

Telmisartan Newsletter
  • FDA News Recap: June 2025 02 Jul 2025 15:05 GMT

    … Food and Drug Administration (FDA)! June 2025 … Medicines announced FDA approval of GMRx2 (WIDAPLIK), a novel triple-combination pill of telmisartan … phase 3 trials and the VERONICA … Treatment of Alkaptonuria On June 19, 2025, Cycle Pharmaceuticals announced FDA

  • Q2 2025 Recap: Cardiology News and Updates 04 Jul 2025 22:03 GMT

    … -102 gene editing medicine to lower low-density … Phase 1b Heart-2 trial. FDA Accepts NDA Submission … pill triple combination therapy—telmisartan, amlodipine, and indapamide—approved for initial treatmentdrugs. Based on positive results from 2 phase 3 trials

  • Spinal Microtissues Made From ALS Patients Enable Personalized Drug Screening 24 Jun 2025 09:13 GMT

    … three years and no effective treatments. In ALS, motor … potential new treatments, the researchers tested 190 FDA-approved drugs in these … platforms for high throughput drug screening projects and for … -Terrón M, et al. Telmisartan is neuroprotective in a hiPSC …

  • FDA Approves New Pill for High Blood Pressure 12 Jun 2025 19:55 GMT

    … only single pill to combine three previously FDA-approved drugs – telmisartan, amlodipine, … would otherwise need multiple pills to manage their blood … trial is underway to find out if the combo treatment … stop taking the medication and consult their doctor

  • State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, Dapagliflozin 22 Jun 2025 15:20 GMT

    … regulatory surveillance, Drugs /;Cosmetics/Medical Devices samples … 124507 Mrk. By : Remedies Pharmaceuticals (India) Pvt Ltd 107A … State Drugs Testing Laboratory, Agartala, Tripura. 36. Telmisartan Tablets I … #47;s. Sarthak Biotech Pvt. Ltd., 198-A …

  • 58 Drug Batches, Including Dexona Fail CDSCO Quality Standards 21 Jun 2025 16:32 GMT

    Drugs Standard Control Organisation (CDSCO) has flagged 58 batches of pharmaceutical … M/s. Nandani Medical Laboratories Pvt. Ltd., 221… Sterillity RDTL, Guwahati 32. Telmisartan Tablets IP 40mg 251TTF025 12 … 2026 M/s. CMG Biotech Pvt. Ltd (Unit II), …

  • SAMPLES OF MANY HIMACHAL DRUG COMPANIES FAILED, ORDERS ISSUED TO RECALL STOCK FROM MARKET 21 Jun 2025 05:57 GMT

    drugs whose samples failed include those for the treatment … simultaneously. These include Telmisartan, a vaccine for … Medipol Pharmaceuticals of Baddi are included. State Drug Controller … Apart from these, medicines like Vitamin Supplements, Aceclofenac …

  • FDA Approves Triple Combination Drug GMRx2 (WIDAPLIK) for Hypertension Treatment 16 Jun 2025 16:02 GMT

    … novel, single-pill combination of telmisartan, amlodipine, and … only FDA-approved triple combination medication for … both trials, with no increase in treatment withdrawal … telmisartan, amlodipine, indapamide, or other sulfonamide-derived drugs.1 A global trial

  • Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™ 16 Jun 2025 12:25 GMT

    FDA) approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a novel single pill combination treatment … in supporting George Medicines throughout their pivotal trial and the … and consultancy that helps biotech and pharmaceutical companies bring novel …

  • FDA Approves First Triple-Drug Polypill for Initial Hypertension Treatment 13 Jun 2025 00:14 GMT

    … proprietary single pill combination of three medicines: telmisartan, amlodipine and … those just starting treatment.” The FDA approval is based … of its component drugs. In both trials WIDAPLIK significantly … 700-patient TRIUMPH trial undertaken in Sri Lanka …

Satisfied with the content?

Continue to create your account.